Abstract:Background: Demodex mites are related to some inflammatory diseases such as rosacea and blepharitis and could be harmful in patients with immunodeficiency or immunosuppression, especially notable in patients using biologic like dupilumab. In order to have an objective observation of different anti-Demodex strategies, we conducted this study, based on interventional clinical evidence with quantified Demodex mite data. Methods: We used the PubMed, Embase, ClinicalTrials.gov, Medline, and International Clinical Trials Registry Platform (ICTRP) as databases. To assess the risk of bias, the RoB2 and ROBINS-I tools were used. The certainty of evidence was assessed following the GRADE guideline. Furthermore, the effect sizes (ESs) of different strategies were compared in different time periods (0-1, 1-2, 2-3, >3 months), as well as Demodex decrease rates. Results: 1,618 studies were identified in the databases, with 21 of which included in the final quantitative synthesis. Interventions in these studies included ivermectin, tea tree oil (TTO), permethrin, crotamiton, metronidazole, light therapies, combined therapies, and other therapies. During 0-1 month, the ES varied from 0.07 (cleanser) to 1.95 (systemic ivermectin-metronidazole). During 1-2 months, the ES varied from 0.88 (topical permethrin) to 4.40 (topical ivermectin). During 2-3 months, the ES varied from 0.79 (topical permethrin) to 8.37 (topical ivermectin). During the time of 3 months, the ES varied from 0.59 (topical permethrin) to 2.25 (intense pulsed light [IPL]). In terms of Demodex decrease rates, topical ivermectin, TTO, permethrin, IPL, and baby shampoo had achieved a nearly 100% decrease. The reported adverse events were mostly mild, without severe adverse events reported in any of the studies. Conclusions: We found ivermectin (topical and systemic), ivermectin-metronidazole (topical), and TTO (topical) are promising anti-Demodex interventions. In addition to traditional pharmacotherapy, light therapies, especially IPL and skin cleansing, could also be considered as effective methods to control Demodex mite infestation.

Retrospective Analysis of the Association Between Demodex Infestation and Rosacea

Data on Demodex Ectoparasite Infestation in Patients Attending an Outpatient Clinic in Greece

Facial Dermatosis Associated with Demodex: a Case-Control Study

Evaluation of the relationship between Demodex infestation and obesity in rosacea patients

Skin-homing T-cell responses associated with Demodex infestation and rosacea

Rosacea, an infectious disease: why rosacea with papulopustules should be considered a demodicosis. A narrative review

Association of blepharitis with Demodex: a meta-analysis.

A Meta-Analysis of Association Between Acne Vulgaris and Demodex Infestation

Presence of Demodex spp. on the face and scalp in patients affected by papulopustular rosacea of face

Which factors influence Demodex proliferation? A retrospective pilot study highlighting a possible role of subtle immune variations and sebaceous gland status

Investigation of Factors Associated with Gut Microbiota in Demodex-associated Skin Conditions

Detection of demodex mites in papulopustular rosacea using microscopic examination and polymerase chain reaction: a comparative case-control study

The role of altered cutaneous immune responses in the induction and persistence of rosacea

Meta-analysis on relationship between Demodex infection and individual hygienic habits

Follicular scales, scalp and ocular involvement in patients with papulopustular rosacea: prevalence and association with Demodex mite proliferation

Current research and clinical trends in rosacea pathogenesis

Relationship between rosacea and dietary factors: A multicenter retrospective case-control survey.

Sociodemographic characteristics and risk factor analysis of Demodex infestation (Acari: Demodicidae)

The Prevalence of Demodex spp. Infestation in Dermatological Patients in Northern Poland

Comparison of Different Anti-Demodex Strategies: A Systematic Review and Meta-Analysis

[Demodex and ocular surface disease]